PAO TMK (TRMK)
Moscow Exchange · Russia · prices in RUB · close of 19 Oct 2026
Key indicators
| Last close | RUB 70.50 |
|---|---|
| 52-week range | 45.02 – 114.64 |
| Return, 1 month / 3 months | +20.4% / +28.1% |
| Return, 1 year / 3 years | −37.8% / −60.0% |
| Trend | Below its 200-day average |
| RSI (14) | 78 |
| Volatility (1 year) | 44.5% |
| Worst drawdown (1 year) | -60.1% |
| Average daily value traded | 175.98M RUB |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
PAO TMK is a Russian manufacturer of steel pipes based in Moscow. The company produces seamless and welded pipe products, including large-diameter pipes used in pipeline construction, along with tubular goods for industrial applications. Its main customers are oil and gas companies and other industrial firms that need pipe for drilling, transportation and infrastructure work. TMK operates manufacturing facilities in Russia and also serves customers in other countries through its pipe-making and related operations.
On this site PAO TMK appears as a stock on the Moscow Exchange (Russia), code TRMK, with prices in Russian rubles (RUB). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
PAO TMK (TRMK) trades on the Moscow Exchange in Russia. It last closed at RUB 70.50 on 19 October 2026.
Its price-based Market X-Ray is 37 out of 100 (a weak price profile), ranking 181 of 250 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 37.8% and over the last three months it rose 28.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Moscow Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 27 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -10.7% | ||
| From 52-week high | -38.1% | ||
| Momentum | 39 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 28.1% | ||
| 6-month return | -25.8% | ||
| 12-month return, skipping the last month | -48.4% | ||
| Stability (higher is calmer) | 21 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 44.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -60.1% | ||
| Liquidity | 80 · Strong | Trades actively. | |
| Average daily value traded | 175.98M RUB | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +16.9% |
|---|---|
| 1 month | +20.4% |
| 3 months | +28.1% |
| 6 months | −25.8% |
| 1 year | −37.8% |
| 3 years | −60.0% |
| 5 years | +34.7% |
Signals
| 50-day / 200-day average | 59.70 / 78.92 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.64 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 Sep 2024 | RUB 15.0600 |
| 27 May 2024 | RUB 3.3900 |
| 31 Jan 2024 | RUB 15.8400 |
| 5 Sep 2023 | RUB 13.4500 |
| 31 Jan 2023 | RUB 6.7800 |
| 9 Sep 2022 | RUB 9.6800 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Moscow Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.